1035700-05-0

Upstream product

• 1072-67-9 5-methylisoxazol-3-ylamine 
• 7693-46-1 4-Nitrophenyl chloroformate 

Downstream Products

• 1395051-12-3 N-(5-methyl-3-isoxazolyl)-N'-[4-(2-[2-methyl-6-(4-methylpiperazino)-4-pyrimidinyl]amino-1,3-thiazol-5-yl)phenyl]urea 
• 1395051-45-2 N₁-5-[4-([(5-methyl-3-isoxazolyl)amino]carbonylamino)phenyl]-1,3-thiazol-2-yl-4-(2-morpholinoethoxy)benzamide 
• 1395050-56-2 N₁-3-[3-methyl-4-([(5-methyl-3-isoxazolyl)amino]carbonylamino)phenyl]-1H-5-pyrazolyl-4-[(4-methylpiperazino)methyl]benzamide 

Relevant academic research and scientific papers

IDO INHIBITORS

There are disclosed compounds that modulate or inhibit the enzymatic activity of indoleamine 2,3-dioxygenase (IDO), pharmaceutical compositions containing said compounds and methods of treating proliferative disorders, such as cancer, viral infections and/or autoimmune diseases utilizing the compounds of the invention.

INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE (IDO)

There are disclosed compounds that modulate or inhibit the enzymatic activity of indoleamine 2,3-dioxygenase (IDO), pharmaceutical compositions containing said compounds and methods of treating proliferative disorders, such as cancer, viral infections and/or inflammatory disorders utilizing the compounds of the invention.